Paper38498331
Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes.
Shang Y and 7 others. Diabetes Care, 2024. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes. Papers, record 38498331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38498331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Metabolic Syndrome | Major topic |
| Humans | |
| Male | |
| Middle Aged | |
| Female | |
| Aged | |
| Sweden | |
| Liver Diseases | |
| Risk Factors |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| The Swedish Research Council | PubMed | |||
| Mag-TarmFonden, Swedish Gastroenterology Society | PubMed | |||
| Pfizer | PubMed | |||
| Karolinska Institutet | PubMed |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32960654 | Validity of administrative codes associated with cirrhosis in Sweden. | Scand J Gastroenterol | 2020 | https://conductscience.org/library/papers/32960654 | PubMed |
| 2 | 31009793 | Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes. | Clin Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/31009793 | PubMed |
| 3 | 12055590 | Diabetes increases the risk of acute hepatic failure. | Gastroenterology | 2002 | https://conductscience.org/library/papers/12055590 | PubMed |
| 4 | 24890439 | Mortality from chronic liver diseases in diabetes. | Am J Gastroenterol | 2014 | https://conductscience.org/library/papers/24890439 | PubMed |
| 5 | 35421424 | Taking a risk-based approach to testing for liver disease in primary care, a step in the right direction. | J Hepatol | 2022 | https://conductscience.org/library/papers/35421424 | PubMed |
| 6 | 21658213 | External review and validation of the Swedish national inpatient register. | BMC Public Health | 2011 | https://conductscience.org/library/papers/21658213 | PubMed |
| 7 | 16176206 | The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003. | Diabet Med | 2005 | https://conductscience.org/library/papers/16176206 | PubMed |
| 8 | 28803953 | Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. | J Hepatol | 2017 | https://conductscience.org/library/papers/28803953 | PubMed |
| 9 | 36626630 | The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. | Hepatology | 2023 | https://conductscience.org/library/papers/36626630 | PubMed |
| 10 | 19504049 | The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. | Eur J Epidemiol | 2009 | https://conductscience.org/library/papers/19504049 | PubMed |
| 11 | 35798021 | The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. | Lancet Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/35798021 | PubMed |
| 12 | 35371259 | Bidirectional Association between Hypertension and NAFLD: A Systematic Review and Meta-Analysis of Observational Studies. | Int J Endocrinol | 2022 | https://conductscience.org/library/papers/35371259 | PubMed |
| 13 | 18767000 | The completeness of the Swedish Cancer Register: a sample survey for year 1998. | Acta Oncol | 2009 | https://conductscience.org/library/papers/18767000 | PubMed |
| 14 | 33724511 | Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease. | Hepatology | 2021 | https://conductscience.org/library/papers/33724511 | PubMed |
| 15 | 25550056 | Diabetes care--improvement through measurement. | Diabetes Res Clin Pract | 2014 | https://conductscience.org/library/papers/25550056 | PubMed |
| 16 | 28342948 | Waist/Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index: A Population-based Cohort Study. | Clin Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/28342948 | PubMed |
| 17 | 16341841 | Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. | Diabetologia | 2006 | https://conductscience.org/library/papers/16341841 | PubMed |
| 18 | 19805654 | Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. | Circulation | 2009 | https://conductscience.org/library/papers/19805654 | PubMed |
| 19 | 22792295 | The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation. | PLoS One | 2012 | https://conductscience.org/library/papers/22792295 | PubMed |
| 20 | 7662841 | Applying Cox regression to competing risks. | Biometrics | 1995 | https://conductscience.org/library/papers/7662841 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42771812 | Association Between Visceral Adiposity Index and Metabolic Syndrome and Its Components: Evidence From the PERSIAN Guilan Cohort Study. | Endocrinol Diabetes Metab | 2026 | https://conductscience.org/library/papers/42771812 | PubMed |
| 42671251 | Upcoming therapies for steatotic liver disease: Translating breakthroughs into clinical practice. | J Intern Med | 2026 | https://conductscience.org/library/papers/42671251 | PubMed |
| 42639235 | Metabolic Syndrome: From Mechanisms to Therapeutic Interventions. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42639235 | PubMed |
| 42603840 | The liver in diabetes: current state and future perspectives. | Diabetologia | 2026 | https://conductscience.org/library/papers/42603840 | PubMed |
| 42588152 | The MASLD-Cardio-Oncology Triangle: Dietary Patterns, Metabolic Remodelling and Implications for Cancer Therapy Tolerance. | Nutrients | 2026 | https://conductscience.org/library/papers/42588152 | PubMed |
| 42562881 | Screening and diagnosis of liver disease in diabetes: a guide and evidence-based assessment. | Diabetologia | 2026 | https://conductscience.org/library/papers/42562881 | PubMed |
| 42334798 | Peripheral and Autonomic Diabetic Neuropathy and Their Additive Risk of Major Adverse Liver Outcomes in Type 2 Diabetes. | Adv Ther | 2026 | https://conductscience.org/library/papers/42334798 | PubMed |
| 42216178 | A culturally adapted online Mediterranean diet intervention for metabolic dysfunction-associated steatotic liver disease (TIMA): study protocol for a randomized controlled trial. | Trials | 2026 | https://conductscience.org/library/papers/42216178 | PubMed |
| 41687818 | Longitudinal changes in cardiometabolic risk factors are associated with changes in liver stiffness in adults with MASLD. | J Hepatol | 2026 | https://conductscience.org/library/papers/41687818 | PubMed |
| 41645665 | Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort. | J Intern Med | 2026 | https://conductscience.org/library/papers/41645665 | PubMed |
| 41630354 | Associations of Albuminuria and Metabolic Syndrome Traits With Fracture Risk in Patients With Type 2 Diabetes: A Population-Based Cohort Study. | J Cachexia Sarcopenia Muscle | 2026 | https://conductscience.org/library/papers/41630354 | PubMed |
| 41431489 | Correlation Between the Levels of Fasting and Postprandial ApoB48 with Metabolic Syndrome: A Cross-Sectional Study. | Diabetes Metab Syndr Obes | 2025 | https://conductscience.org/library/papers/41431489 | PubMed |
| 41405814 | Enhancing the interpretation of diabetes-related risk in ALD-ACLF: a methodological perspective. | Hepatol Int | 2026 | https://conductscience.org/library/papers/41405814 | PubMed |
| 41368122 | Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver disease. | World J Hepatol | 2025 | https://conductscience.org/library/papers/41368122 | PubMed |
| 41321337 | Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease with Clinically Significant Fibrosis in Obese Patients with Type 2 Diabetes Mellitus - China, 2017-2024. | China CDC Wkly | 2025 | https://conductscience.org/library/papers/41321337 | PubMed |
| 41262775 | Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case-control study in Sweden. | BMJ Public Health | 2025 | https://conductscience.org/library/papers/41262775 | PubMed |
| 41190151 | Cardiovascular-kidney-metabolic progression associated with major adverse liver outcomes: mediating roles of plasma metabolites. | Front Nutr | 2025 | https://conductscience.org/library/papers/41190151 | PubMed |
| 41058240 | Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approach. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/41058240 | PubMed |
| 40980971 | Target Trial Emulations of GLP-1 and Dual GLP-1/GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes. | Liver Int | 2025 | https://conductscience.org/library/papers/40980971 | PubMed |
| 40775615 | Predictive factors for metabolic syndrome in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). | BMC Gastroenterol | 2025 | https://conductscience.org/library/papers/40775615 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38498331
GET https://conductscience.org/api/papers/v1/38498331/references?page=2